CAR-T Cells That Secrete CD19 Antibodies Effective Against B-ALL
Summary by Inside Precision Medicine
4 Articles
4 Articles
All
Left
Center
Right
1
CAR-T Cells That Secrete CD19 Antibodies Effective Against B-ALL
Researchers at Josep Carreras Leukaemia Research Institute and Hospital 12 de Octubre in Spain have tested a new CAR-T immunotherapy that can effectively maintain its treatment efficacy longer in B-cell acute lymphoblastic leukemia (B-ALL) versus current therapies. This new approach, which targeted the CD19 protein, is the latest advance in improving therapeutic response for patients who have relapsed or did do not respond to current standard tr…
Coverage Details
Total News Sources4
Leaning Left0Leaning Right1Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage